Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 3/2002

01-04-2002 | Originales

Influencia del inicio del tratamiento con factores estimulantes de colonias de granulocitos en la recuperación de la neutropenia tras dosis altas de quimioterapia en pacientes con cáncer de mama

Authors: Juan José Pérez Ruixo, Pilar Azagra Ros, Vicente Germán Casabo Alos, Nicolás Víctor Jiménez Torres, Javier García-Conde Bru

Published in: Clinical and Translational Oncology | Issue 3/2002

Login to get access
Metadata
Title
Influencia del inicio del tratamiento con factores estimulantes de colonias de granulocitos en la recuperación de la neutropenia tras dosis altas de quimioterapia en pacientes con cáncer de mama
Authors
Juan José Pérez Ruixo
Pilar Azagra Ros
Vicente Germán Casabo Alos
Nicolás Víctor Jiménez Torres
Javier García-Conde Bru
Publication date
01-04-2002
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 3/2002
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02732343

Other articles of this Issue 3/2002

Clinical and Translational Oncology 3/2002 Go to the issue

Revisiones

The kaposi’s sarcoma associated herpesvirus: a model for viral oncogenesis

Originales

Functional evaluation after reconstruction of the anterior floor of the mouth with free flaps in patients with head and neck cancer

Editorial

Nuevo Equipo de Dirección y Redacción

Revisiones

Lesiones prostáticas neoplásicas y no neoplásicas con células claras

Notas Clínicas

Endobronquial metastasis of a ductal carcinoma in a male

Originales

Ano-rectal sphincter preservation following preoperative chemoradiation in cT3–4Nx rectal cancer: influence of tumor distance and downstaging
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits